Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials M Kanbay, S Copur, D Siriopol, AB Yildiz, A Gaipov, DH Van Raalte, ... Diabetes, Obesity and Metabolism 25 (12), 3766-3778, 2023 | 23 | 2023 |
The risk for chronic kidney disease in metabolically healthy obese patients: a systematic review and meta‐analysis M Kanbay, S Copur, D Siriopol, AB Yildiz, M Berkkan, KR Tuttle, C Zoccali European journal of clinical investigation 53 (1), e13878, 2023 | 18 | 2023 |
The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis M Kanbay, S Copur, D Siriopol, AB Yildiz, M Berkkan, R Popa, NB Hasbal, ... Clinical Kidney Journal 16 (5), 817-826, 2023 | 16 | 2023 |
An update review on hemodynamic instability in renal replacement therapy patients AB Yildiz, S Vehbi, A Covic, A Burlacu, A Covic, M Kanbay International Urology and Nephrology 55 (4), 929-942, 2023 | 13 | 2023 |
Physical exercise in kidney disease: A commonly undervalued treatment modality M Kanbay, S Copur, AB Yildiz, C Tanriover, F Mallamaci, C Zoccali European Journal of Clinical Investigation 54 (2), e14105, 2024 | 12 | 2024 |
Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury? S Copur, A Yildiz, C Basile, KR Tuttle, M Kanbay Journal of nephrology 36 (1), 31-43, 2023 | 11 | 2023 |
BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming K Sevinç, GG Sevinç, AD Cavga, M Philpott, S Kelekçi, H Can, AP Cribbs, ... Stem cell reports 17 (12), 2629-2642, 2022 | 9 | 2022 |
Substitution of sugar-sweetened beverages for other beverages: can it be the next step towards healthy aging? LA Ertuglu, B Afsar, AB Yildiz, A Demiray, A Ortiz, A Covic, M Kanbay Current Nutrition Reports, 1-14, 2021 | 9 | 2021 |
Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosis M Kanbay, AB Yildiz, D Siriopol, S Vehbi, NB Hasbal, YE Kesgin, ... International Urology and Nephrology 55 (4), 1025-1032, 2023 | 7 | 2023 |
A promising tool: triglycerides–glucose index to stratify the risk of cardiovascular events in chronic kidney disease F Yildirim, AB Yildiz, M Kanbay Clinical Kidney Journal 15 (9), 1653-1656, 2022 | 6 | 2022 |
The role of body mass index on IgA nephropathy prognosis: a systematic review and meta-analysis M Kanbay, AB Yildiz, F Yavuz, A Covic, A Ortiz, D Siriopol International Urology and Nephrology 54 (10), 2567-2579, 2022 | 5 | 2022 |
Assessment of hypertension in obstructive sleep apnea by ambulatory blood pressure monitoring: a systematic review and meta-analysis AB Yildiz, D Siriopol, S Vehbi, Ö Özgü, B Yağ, A Kanbay, M Kanbay Blood Pressure Monitoring 27 (5), 285-296, 2022 | 5 | 2022 |
Intrauterine life to adulthood: a potential risk factor for chronic kidney disease M Kanbay, S Copur, AB Yildiz, A Covic, A Covic, P Ciceri, L Magagnoli, ... Nephrology Dialysis Transplantation 38 (12), 2675-2684, 2023 | 4 | 2023 |
Amnioinfusion vs. standard management for the second trimester PPROM: a systematic review and meta-analysis of observational studies and RCTs E Celik, AB Yildiz, S Guler Cekic, C Unal, I Ayhan, R Melekoglu, T Gursoy The Journal of Maternal-Fetal & Neonatal Medicine 36 (2), 2230511, 2023 | 3 | 2023 |
Perspectives on current models of Friedreich’s ataxia S Kelekçi, AB Yıldız, K Sevinç, DU Çimen, T Önder Frontiers in Cell and Developmental Biology 10, 958398, 2022 | 3 | 2022 |
Is there any robust evidence showing that SGLT2 inhibitor predisposes to cancer? S Copur, AB Yildiz, A Covic, M Kanbay European Journal of Clinical Investigation 54 (2), e14131, 2024 | 2 | 2024 |
Capsaicin suppresses ciliary function, while inducing permeability in bronchial epithelial cell cultures of COPD patients HI Toy, AB Yildiz, D Tasdemir Kahraman, S Ilhan, O Dikensoy, H Bayram Frontiers in Pharmacology 13, 996046, 2022 | 2 | 2022 |
Generation of transgene-free iPSC lines from three patients with Friedreich’s ataxia (FRDA) carrying GAA triplet expansions in the first intron of FXN gene S Kelekçi, D Uğurlu-Çimen, AB Demir, B Özçimen, AB Yıldız, MB Karakuş, ... Stem Cell Research 54, 102438, 2021 | 2 | 2021 |
Angiopoietin as a Novel Prognostic Marker in Kidney Disease AB Yildiz, S Copur, C Tanriover, F Yavuz, S Vehbi, A Gaipov, L Magagnoli, ... Blood Purification 53 (6), 425-435, 2024 | | 2024 |
Discrepancy between IDSA and ESGBOR in Lyme disease: Individual participant meta‐analysis in Türkiye AB Yıldız, E Çetin, F Pınarlık, Ş Keske, F Can, Ö Ergönül Zoonoses and Public Health 71 (4), 337-348, 2024 | | 2024 |